
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
A column covering the outsourcing industry.
over 23 years ago
A Stress Testing Benchmarking Studyover 23 years ago
Cleanroom Pressurization Methodologyover 23 years ago
PhRMA Perspectives on Drug Substance Regulatory Filing Issuesover 23 years ago
Manufacturing Capability Key to Global Health Advancesover 23 years ago
February 2003